PHARMACY

Local JDRF chapter names chair of annual Walk to Cure Diabetes

BY Allison Cerra

PORTLAND, Ore. The Oregon/SW Washington chapter of the Juvenile Diabetes Research Foundation and LifeWise Health Plan of Oregon have announced that David Lechner, VP sales and marketing for LifeWise, will serve as chair for the annual Walk to Cure Diabetes.

The annual walk, which will be held Oct. 3, is a fundraising event on behalf of Type 1 diabetes research. Last year, more than 6,000 people participated in the event, raising more than $300,000 for diabetes research. LifeWise Health Plan of Oregon is a provider of healthcare coverage and related services to 1.6 million members and their families.

“LifeWise is proud to be working together with JDRF on such an important goal. Every thirty minutes, a child is diagnosed with Type 1 diabetes. Additionally, recent statistics reveal that healthcare expenditures surrounding diabetes cost our nation in excess of $130 billion annually,” said Lechner, who was diagnosed with Type 1 diabetes at 22 years old. “That’s why we are committed to raising money for cutting-edge research. By working together, we can make a difference.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA tentatively approves Sun’s Namenda generic

BY Alaric DeArment

MUMBAI, India The Food and Drug Administration has given tentative approval to a generic Alzheimer’s disease drug made by Sun Pharmaceutical Industries, Sun announced Saturday.

The FDA gave the tentative approval to Sun’s memantine tablets in the 5-mg and 10-mg strengths. The drug is a generic version of Forest Labs’ Namenda, which has annual U.S. sales of around $1.2 billion, according to Sun.

A tentative approval means that a generic drug meets the FDA’s conditions for approval, but the agency cannot grant final approval until the branded drug’s patents expire. Forest’s patent for Namenda expires in April 2015, according to FDA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Meijer offering free metformin to customers

BY Allison Cerra

GRAND RAPIDS, Mich. Meijer announced plans Monday to begin offering metformin immediate release, one of the most commonly prescribed treatments for Type 2 diabetes, at no cost to those with a prescription.

Meijer’s program — which will include doses prescribed in 500-mg, 850-mg and 1,000-mg tablets — joins other Meijer healthy-living initiatives designed to provide no-cost medicine to shoppers, including such initiatives as free children’s antibiotics and prenatal vitamins for women with a prescription. To date, Meijer has filled more than 5 million free antibiotic prescriptions, and more than 500,000 prescriptions for free prenatal vitamins. Combined, Meijer has provided a total cost savings to consumers of more than $90 million.

Meijer is one of several store chains that recently has announced free metformin offerings for customers. Last month, Publix launched a multifaceted program designed to assist customers and associates living with diabetes.

“Meijer is pleased to add metformin immediate release to our free medication program,” said Effie Steele, clinical services coordinator for the Grand Rapids, Mich.-based retailer. “As our population ages, Type 2 diabetes cases continue to grow. Adding metformin immediate release to Meijer’s free medication program, while providing other ways to manage diabetes through the various healthy living solutions offered in our stores, reinforces our commitment to promote healthy lifestyles for all of our customers.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?